Over the 90-day window ending February 07, 2026, Indivior Pharmaceuticals's three dominant insider ownership positions are held by Director Daniel A Ninivaggi (20.64K shares), Director Mark Stejbach (20.57K shares), Director David E. Wheadon (20.35K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Daniel A Ninivaggi | 20,645 | 28 Jan, 2026 | |
| Mark Stejbach | 20,569 | 28 Jan, 2026 | |
| David E. Wheadon | 20,350 | 28 Jan, 2026 | |
| Keith Humphreys | 9,524 | 28 Jan, 2026 | |
| Juliet Thompson | 7,572 | 28 Jan, 2026 | |
| Barbara Ryan | 5,685 | 28 Jan, 2026 | |
| Stuart A Kingsley | 4,642 | 28 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 26 Jan, 2026 | Daniel A Ninivaggi | Common Stock | A | 3,722 | $0.00 | 20,645 | D | A |
| 26 Jan, 2026 | Stuart A Kingsley | Common Stock | A | 3,722 | $0.00 | 4,642 | D | A |
| 26 Jan, 2026 | Mark Stejbach | Common Stock | A | 3,722 | $0.00 | 20,569 | D | A |
| 26 Jan, 2026 | Juliet Thompson | Common Stock | A | 3,722 | $0.00 | 7,572 | D | A |
| 26 Jan, 2026 | David E. Wheadon | Common Stock | A | 5,955 | $0.00 | 20,350 | D | A |
| 26 Jan, 2026 | Barbara Ryan | Common Stock | A | 3,722 | $0.00 | 5,685 | D | A |
| 26 Jan, 2026 | Keith Humphreys | Common Stock | A | 3,722 | $0.00 | 9,524 | D | A |
| 05 Jan, 2026 | Daniel A Ninivaggi | Ordinary Shares | A | 775 | $35.39 | 16,923 | D | P |
| 05 Jan, 2026 | Mark Stejbach | Ordinary Shares | A | 775 | $35.39 | 16,847 | D | P |
| 05 Jan, 2026 | David E. Wheadon | Ordinary Shares | A | 1,771 | $35.39 | 14,395 | D | P |
| 05 Jan, 2026 | Barbara Ryan | Ordinary Shares | A | 775 | $35.39 | 1,963 | D | P |
| 05 Jan, 2026 | Keith Humphreys | Ordinary Shares | A | 775 | $35.39 | 5,802 | D | P |